Presented by: One in three women and one in four men in the United States have experienced intimate partner violence (IPV) in their lifetime— and the risks to survivors are severe. There is universal concern from clinicians, researchers, agencies, and advocacy groups that these numbers may dramatically rise as a result of COVID-19 related to stay at home orders and stressors. At the same time, we know the rate of IPV screening in primary care is low (1.5-12% of patients). It is imperative that clinicians screen patients and address their needs in relation to IPV. In this presentation, we will discuss: 1: The importance of screening for IPV in a primary care setting 2: Universal education/screening protocol for IPV and adaptations during COVID-19 3: Ways to apply this protocol in your clinical setting

Date: April 17, 2022